Essential diabetes drugs' prices

Essential diabetes drugs’ prices are constrained by a pricing authority

Two essential anti-diabetic medications—Sitagliptin-Metformin combination and Linagliptin-Metformin combination—have been placed under price control by India’s drug pricing authority. The National Pharmaceutical Pricing Authority has set retail prices for 45 drug formulations, including the two anti-diabetic medications (NPPA). Since Merck Sharp and Dohme’s (MSD) Sitagliptin patent expired last month, several generic versions of the drug have […]

Continue Reading
Dietary changes can lead to diabetes remission and prevention

Dietary changes can lead to diabetes remission and prevention, according to a study

In New Delhi: Over 80 million Indians are estimated to have pre-diabetes, and there are 74 million people in the country who are estimated to have diabetes. A recent national study, the ICMR-INDIAN research, which employed a linear regression model and quadratic programming, demonstrated that diabetes remission (reversal) could be attained if the carbohydrate content […]

Continue Reading